RUNX1 and cancer: These mutations change the expression of genes involved in proliferation and adhesion, and in signaling pathways such as Wnt and MAPK, as well as the gain of copy-number alterations associated with cancer progression (e.g., deletion of RUNX1, a lineage specific master regulator controlling mammary luminal cell fate).